80 CENTS PRICE TARGET, page-93

Good lateral thinking Disco. I hadn't considered the two having complementary use for breakthrough cancer pain treatment.

We know the wave is coming, so I thought it would be interesting to ask chat GPT which current clinical trial for breakthrough cancer pain has the best chance of FDA approval.

Judging by the lack of Aussie interest in the stock, I was a bit worried it'd list a dozen trials and no mention of IRX 211.

Its answer, however, reaffirmed my investment thesis is rock solid.

For transparency, here is chat GPT's actual response, and for completeness, the question has been included, too:





GLTAH